Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)
Renu Agnihotri(Maine Medical Center), Lucy Liaw(MaineHealth), Howard C. Crawford(Henry Ford Health System), Hirotaka Haro(University of Yamanashi), Lynn M. Matrisian(Pancreatic Cancer Action Network), Matthew C. Havrda(Dartmouth College)
Cited by 422
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k